1. Home
  2. Analysis
  3. Emtriva
  4. Naproxen

Emtriva and Naproxen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emtriva (emtricitabine) and Naproxen (naproxen). Common drug interactions include anxiety among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Emtriva and Naproxen. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,032 Naproxen users. Check the latest studies of Naproxen.

On Jul, 20, 2026

20 people who take Emtriva and Naproxen together, and have interactions are studied.

Emtriva and Naproxen drug interactions.

What are the common drug interactions of Emtriva and Naproxen, by gender? *:

female:

  1. Anxiety
  2. Emotional distress
  3. Depression
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Bone density decreased
  6. Gait disturbance
  7. Osteoporosis (bones weak and more likely to break)
  8. Renal impairment (severely reduced kidney function)
  9. Blood creatinine increased
  10. Chronic kidney disease

male:

  1. Emotional distress
  2. Anxiety
  3. Bone loss
  4. Mobility decreased (ability to move is reduced)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  7. Hand fracture
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Impaired work ability
  10. Tooth loss

What are the common drug interactions of Emtriva and Naproxen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood creatinine increased
  2. Chronic kidney disease
  3. Mobility decreased (ability to move is reduced)
  4. Protein urine present
  5. Renal failure (kidney dysfunction)
  6. Rib fracture
  7. Weight increased
  8. Anaemia (lack of blood)
  9. Nephrogenic anaemia (anaemia due to kidney disease)

30-39:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Depression
  4. Emotional distress
  5. Fracture
  6. Fractured sacrum
  7. Gait disturbance
  8. Hip fracture
  9. Joint dislocation (a joint position is changed from normal position)
  10. Joint injury

40-49:

  1. Chronic kidney disease
  2. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Emotional distress
  6. Osteoporosis (bones weak and more likely to break)
  7. Bone pain
  8. Drug resistance (reduction in effectiveness of a drug)
  9. Gait disturbance
  10. Renal impairment (severely reduced kidney function)

50-59:

  1. Anxiety
  2. Emotional distress
  3. Bone density decreased
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Osteoporosis (bones weak and more likely to break)
  6. Bone loss
  7. Chronic kidney disease
  8. Fatigue (feeling of tiredness)
  9. Mobility decreased (ability to move is reduced)
  10. Osteonecrosis (death of bone)

60+:

  1. Osteoporosis (bones weak and more likely to break)
  2. Emotional distress
  3. Anxiety
  4. Bone loss
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance
  7. General physical health deterioration (weak health status)
  8. Libido decreased (loss of interest in sex)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Nephropathy (damage to or disease of a kidney)

What are the existing conditions these people have? *

  1. Hiv Infection: 20 people, 100.00%
  2. Stress And Anxiety: 1 person, 5.00%
  3. Bacterial Infection: 1 person, 5.00%
  4. Bone Density Abnormal: 1 person, 5.00%
  5. Cough: 1 person, 5.00%
  6. Eye Irritation: 1 person, 5.00%
  7. Fungal Infection: 1 person, 5.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
  9. High Blood Pressure: 1 person, 5.00%
  10. Hypersensitivity: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Emtriva and Naproxen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Emtriva and Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emtriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine and naproxen (the active ingredients of Emtriva and Naproxen, respectively), and Emtriva and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.